The present invention relates generally to a multi-lumen catheter having a plurality of separate distal tips and more particularly to an improved split-tip catheter.
Multi-lumen catheters are used for the purpose of creating two or more separate fluid pathways, such as in hemodialysis applications. A primary goal of hemodialysis access is to provide a reliable and effective means of dialysis, which means that a sufficient volume of blood over a period of time must be removed from and returned to the patient. Because the contaminated and cleansed blood must be kept separate for an effective dialysis procedure, a dual lumen catheter is generally used. These dual lumen catheters are usually configured so that there is a shorter lumen that aspirates blood from a blood vessel of a patient to a dialysis machine where it is processed for the removal of toxins, and a longer lumen that infuses the purified blood to the patient. The shorter lumen utilized for aspiration is generally referred to as the “arterial lumen,” while the longer lumen utilized for infusion is generally referred to as the “venous lumen.” The reason for the different lengths is to minimize co-mingling of aspirated and infused blood.
The primary problems occurring in dual lumen dialysis catheters are blood clotting (thrombosis) and fibrin (the protein formed during normal blood clotting that is the essence of the clot) sheath formation. Thrombus and fibrin sheath formation can occlude distal tips of the dialysis catheter lumens, resulting in loss of catheter function when such an occlusion prevents blood flow. This typically occurs initially in the arterial lumen used for aspiration of blood from a patient. A secondary problem relates to the arterial lumen “sucking” against the vessel wall, in which the arterial lumen openings become fully occluded by the patient's vasculature.
To specifically address these problems, a new type of dialysis access catheter has been designed that utilizes independent “free floating” distal tip sections that separate at a distal end of the catheter to theoretically reduce the likelihood of potential occlusion and “sucking” during dialysis treatment. U.S. Pat. No. 6,001,079 to Pourchez and U.S. Pat. Nos. 5,947,953 and 6,190,349 to Ash et al., all incorporated by reference herein, are directed to said new type of catheter, hereinafter referred to as a “split-tip catheter.”
Catheters used for hemodialysis are generally inserted according to standard technique. This includes identifying the location of the central veins in which the catheter is to be inserted, utilizing the Seldinger technique to cannulate the central vein with a guidewire, and passing various instruments over the guidewire until the catheter is in place. In the case of a small diameter catheter made of relatively stiff material (i.e., a percutaneous catheter for acute access), the catheter itself can be passed over the guidewire and into the central vein. In the case of a larger diameter catheter, the passage to the central vein must be widened through the use of dilator(s), after which the catheter can be passed over the guidewire. Another possibility available to the physician is to use an introducer sheath, which is passed over the guidewire (after dilation or simultaneously therewith) forming a path for the catheter to access the central vein.
Due to the configuration of the split-tip catheter, standard insertion techniques must be modified. With respect to non-sheath insertions, the separate distal tip sections must each be passed over the guidewire to ensure their arrival at the targeted central vein without attendant problems. Suggested means for accomplishing this (in a dual lumen catheter) is to pass the back end of the guide wire through the distal end hole of one tip section and out a side hole thereof into the distal end hole of the other tip section (Patel et al., J. Vasc. Interv. Radiol. (2001), vol. 12, pages 376-378). However, such a method can become problematic depending on the placement of the side holes and, in fact, may be impossible in the event that no side holes are provided. With respect to sheathed insertions, the separate distal tip sections may tend to flare outward and catch or “snag” on the inner wall of the delivery sheath thereby preventing smooth delivery of the catheter to the central vein.
There is a need for improvements to split-tip catheters and new configurations thereof, which enhance the design and further alleviate concerns with regard to typical problems encountered in hemodialysis catheters. There is also a need for new configurations and new methods for insertion of split-tip catheters to overcome problems associated therewith
In accordance with the present invention, several embodiments are described, which may be improvements to prior art split-tip catheters or may be novel catheter embodiments heretofore undisclosed. As used herein, the following terms have the following meanings:
“Split-tip catheter” refers to a catheter having a body enclosing at least two lumens and a dividing point that separates at least two tip sections from one another distal thereto, each of the tip sections enclosing at least one lumen and being separated or separable from one another along their length.
“Dividing point” refers to a point along the length of the split-tip catheter distal to which at least two tip sections are separated or are separable from one another.
“Tip section” refers to a portion of the split-tip catheter, enclosing at least one lumen, which is separable or is separated from another tip section along its length distal to a dividing point.
“Inner surface” refers to a surface on a tip section that is facing or adjacent a companion tip section (a tip section that separates or is separable distal to the same dividing point).
“Outer surface” refers to a surface on a tip section that is not facing a companion tip section.
“Separation force” refers to a force required to separate the tip sections from one another.
“Excessive separation force” refers to a force required to separate the tip sections from one another, which is too great to be considered practical for a clinician in a typical setting. By definition, an excessive separation force is required to separate the tip sections of the split tip catheter from one another proximal to the dividing point.
“Cylindrical” is used according to its ordinary meaning (i.e., a shape having a constant circular cross-section).
One improvement to prior art split-tip catheters comprises a unique configuration of each tip section to improve flow characteristics, provide ease of delivery and overcome typical problems associated with hemodialysis catheters. In a dual lumen embodiment, the split-tip catheter comprises a shorter arterial tip section comprising a semi-cylindrical shape with a rounded distal end, and a longer venous tip section comprising a semi-cylindrical shape in a proximal portion which smoothly transitions in a transition region to a cylindrical shape in a distal portion, the cross-sectional size of the distal portion being greater than the cross-sectional size of the proximal portion, the distal portion terminating in an inward bevel. Another improvement comprises the strategic placement of openings placed on the tip sections of the split-tip catheter. With particular respect to an arterial tip section in a dual lumen configuration, the openings are offset both longitudinally and circumferentially so that full 360° fluid flow is realized and problems related to “sucking” against the vessel wall are mitigated.
Another improvement to the prior art split-tip catheters comprises a means for reducing dead space on the surface of the tip sections of a split-tip catheter in the region of separation, which includes, but is not limited to, an opening or openings located on an inner surface of one or more tip sections near a dividing point of the split-tip catheter. In one embodiment of the invention, a hole or opening is positioned on an aspirating lumen tip section. In another embodiment of the invention, a hole or opening is positioned on an infusion lumen tip section. In each of these embodiments, there could be multiple holes or openings on the lumen tip sections. Additionally, the hole(s) or opening(s) could be positioned in many different locations along the length of the tip sections and/or catheter.
An additional improvement to prior art split-tip catheters is related to the delivery thereof either with or without the use of a delivery sheath. With respect to a non-sheathed delivery, the improvement concerns strategic placement of a guidewire opening in the distal end of the venous tip section so that the guidewire is easily passed through the venous tip section and into the arterial tip section. With respect to a sheathed delivery, the improvement relates to a friction-reducing means for reducing friction between the catheter and a delivery sheath. As discussed above, movement of the delivery sheath with respect to the split-tip catheter can result in the inside surface of the delivery sheath engaging the tip sections, which can cause tears in the delivery catheter, problems in the delivery process and other unwanted occurrences.
Thus, in one embodiment of the invention, a bump or protrusion of material is positioned on the outer surface of one or more tip sections adjacent the inside surface of the delivery sheath. In another embodiment of the invention, a ring of material is positioned around the end of one or more tip sections. In yet another embodiment of the invention, an inflatable material is positioned on the outer surface of the catheter in one or more locations to be inflated during delivery to provide a buffer zone for prevention of direct contact of the tip sections with the inside surface of the delivery sheath. Following delivery of the split-tip catheter, said material would be deflated. In still another embodiment, bumps or protrusions of material are positioned on the inside surface of the sheath.
With respect to prior art split-tip catheters that are releasably joined or “splittable,” an improvement is described in which tip sections that are initially joined together distal to a dividing point can be separated along a predetermined length thereof upon an application of a particular separation force. In this aspect of the invention, the separation force required to disjoin the tip sections varies along the length of the tip sections (in the described embodiments the separation force increases from the distal end to the proximal end of the catheter) as the bond between the tip sections is varied.
Thus, in one embodiment, the splittable tip sections are releasably joined to one another distal to a dividing point, enabling split and joined configurations to be interchangeable. In another embodiment of the invention, the bond between the splittable tip sections varies in a continuous fashion along their length in such a way that the force required to separate them is progressively increased in a straight line fashion as measured from a distal end of the tip sections to the dividing point. In yet another embodiment of the invention, the required separation force increases in incremental steps as measured from a distal end of the tip sections to the dividing point. In each of these embodiments, while the tip sections are splittable along a predetermined length of the catheter distal to a dividing point, it should be appreciated that said dividing point is a fixed point beyond which separation can not take place without use of excessive separation force.
These and other embodiments, features and advantages of the present invention will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described
The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected preferred embodiments and are not intended to limit the scope of the invention.
The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
The present invention is directed to multi-lumen catheters with separate distal tips in the form of improvements over prior art split-tip catheters as well as new configurations and embodiments. While the examples and embodiments of a multi-lumen catheter are discussed herein in terms of a dialysis catheter, it should be appreciated that there are many other possible uses for a multi-lumen catheter of the type presented herein. Also, while a currently preferred material is medical grade polyurethane, it should be appreciated that a variety of suitable materials could be utilized to form the multi-lumen catheter of the present invention. Importantly, the material chosen should possess characteristics such as flexibility, durability and relative softness and conformability when placed within a blood vessel.
Referring now to
In addition, although only one dividing point is illustrated in
Referring now to
As shown in
It should be appreciated that even though one hole on inner surface 45 is shown in
While the embodiment shown in
Both tip sections 40 and 50 may include side hole(s) 48 and 58 respectively, positioned near their terminal end for enhanced fluid flow into and out of the tip sections 40 and 50. As should be appreciated by one of skill in the art, many embodiments with respect to the side hole(s) are possible, including an embodiment with no side holes. The side hole(s) 48 and 58 can be positioned at various locations around the circumference of the tip sections 40 and 50 and can be one or several in number. As shown in the embodiment of
Similar to the embodiment shown in
As mentioned, the D-shape of the arterial tip section 124 is unchanged along the full length thereof, having planar surface 130 and a semicircular surface 135 that interconnects rounded corners 136 and 137 at the lateral ends of the arterial tip section 124 (see
In
The positioning of the openings 138-141, as well as the distance therebetween, is very important with respect to the stated goals of facilitating blood flow and maintaining patency of the catheter. By positioning each opening at longitudinal locations offset from one another (and in this case approximately equidistant from one another) as well as at different points around the circumference of the arterial tip section 124, alternative flow through the arterial tip section 124 is permitted, preventing thrombus and fibrin formation as well as “sucking” against the vessel wall. More specifically, the offset positioning on four different sides enables 360° multi-planar flow into the arterial tip section 124 with five effective sides (including the end opening 134) for the receipt of blood, such that total occlusion of the arterial tip section 124 is largely eliminated.
The distal venous tip section 126 comprises a proximal portion 142, a transition region 143 and a distal portion 144. The proximal portion 142 has a semicircular cross-section similar to the arterial tip section 124 that is unchanged from the dividing point to the transition region 143 as can be appreciated by viewing the cross-sections shown in
The transition region 143 connects the proximal portion 142 to the distal portion 144 and comprises a transition shoulder 156. The transition region 143 continuously changes in cross-sectional shape along its length in transitioning from the semicircular shape of the proximal portion 142 to the circular shape of the distal portion 144. As shown, the transition shoulder 156 is positioned on a side of the venous tip section 126 adjacent the arterial tip section 124, although certainly other configurations are possible with respect to positioning of the transition shoulder. In addition, configurations including multiple transition shoulders are contemplated herein.
The shape of the venous lumen 122 transitions from a D-shape in the proximal portion 142 to a circular shape in the distal portion 144, although the actual cross-sectional area of each shape can be manipulated to accommodate the particular application (i.e., the cross-sectional area of the distal portion with respect to the proximal portion can increase, decrease or remain substantially equivalent). In one embodiment, the cross-sectional area for the venous lumen 122 in the distal portion 144 of the venous tip section 126 is standardized to permit all sizes of the catheter to be tunneled subcutaneously during implantation using a single size of tunneling trocar. Thus, the cross-sectional area of the lumen 122 in the proximal portion 142 of the venous tip section 126 (as well as the cross-sectional area of the proximal portion 142 itself) would vary depending on the size of the catheter. One possibility, therefore, would include an increase in cross-sectional area of the venous lumen 122 from the proximal portion 142 to the distal portion 144 of the venous tip section 126. This could have advantages in that the discharge velocity of fluid flowing out of the end 146 would be reduced, translating into less trauma to the vessel and minimized effects related to shear stress. Of course, it should be apparent to one of skill in the art that various combinations of cross-sectional shapes and sizes for the venous lumen 122 are possible along the length thereof, each of which could enjoy certain advantages and benefits.
The distal portion 144 has a cylindrical shape with an open end 146 that is inwardly beveled in the proximal direction toward a plane P132. End opening 148 through the open end 146 is contained in a plane P148 that is shown in
In
The shoulder 156 is penetrated obliquely by a somewhat longitudinally-aligned guidewire aperture 162 that communicates between the exterior of the venous tip section 126 and the venous lumen 122 in transition region 143 and distal portion 144. As clearly seen in
Although the examples herein with respect to a guidewire aperture are discussed in terms of passage of a guidewire therethrough, it will be appreciated by one of skill in the art that an aperture could also be configured for passage of a stylet or other instrument, such as the applicator discussed in U.S. Pat. No. 5,405,341 to Martin, which is incorporated by reference herein. Assuming a larger diameter for a stiffening stylet when compared to a standard guidewire, such an aperture would tend to be greater in size than the described guidewire aperture, although certainly many sizes and shapes are possible, including slits.
Referring to the transition shoulder 156 as seen in
In implanting the split-tip catheter 100, the insertion guidewire 164 is threaded into the catheter 100 by first passing the proximal end thereof into end opening 148 of the venous tip section 126 and along the venous lumen 122 within the distal portion 144, through the guidewire aperture 162 and into the end opening 134 of the arterial tip section 124 where it is advanced along the full length of arterial lumen 120 to exit the catheter tube 114 at a proximal end thereof. This course taken by the guidewire 164 is shown in
In another embodiment of the present invention, a guidewire lumen is formed through the distal portion of the venous tip section, but is separate from the venous lumen. Thus, in this embodiment the distal portion of the venous tip section comprises two lumens whereas the proximal portion of the venous tip section comprises only one. This would be possible, for example, by providing a transition region similar to that shown in
The presence of an additional lumen permits the use of a stiffening stylet as described above, without having to increase the size of the guidewire aperture (which may be advantageous to avoid excessive loss of blood therethrough). Thus, the described embodiment could be formed with or without a guidewire aperture. In the case that a guidewire aperture was not formed through the transition region, the additional lumen could accommodate a guidewire, stiffening stylet or both (in addition to possible other medical instruments). In the case that a guidewire aperture is formed through the transition region, a guidewire and stiffening stylet could be used simultaneously if so desired.
An alternate embodiment of the present invention with respect to the configuration of the tip sections is provided in
The venous tip section 226 has a proximal portion 242, a transition region 243 and a distal portion 244 and has an end 246 with an opening 248 therethrough (see
In the vicinity of the curved outer wall of the cylindrical distal portion 244, the floor 260 of the recess 258 is penetrated by a guidewire aperture 262 that communicates between the exterior of the venous tip section 226 and the venous lumen 222 (
While the split-tip catheters 100 and 200 are configured to allow for sheathless delivery into a cardiovascular system of a patient due to the presence of guidewire apertures 162 and 262, respectively, an improvement to related to the sheathed delivery of split-tip catheters is illustrated in
One potential method for alleviating this problem would be to use a larger diameter sheath so that the tip sections will have a greater distance to travel to come in contact with the inside surface of the sheath when the friction forces act on the tip sections, thereby minimizing the chance of a snag. However, this solution is flawed in that snags are still possible and the risk of air embolism is amplified due to the increase in surface area between the catheter and the sheath.
In
Another embodiment for reducing friction comprises an inflatable material being positioned on one or more points along the catheter. In this embodiment, a small inflation lumen is positioned on the inner or outer of either or both arterial or venous lumens, extending from the proximal end of the catheter to the point on the catheter containing the inflatable material. When the catheter is positioned for delivery within a delivery sheath, air, gas or liquid is transmitted through the inflation lumen to the inflatable material, expanding said material into contact with the inner of the delivery sheath. Preferably, the inflatable material would be positioned close to the distal end of the catheter on the tip sections so that the goal of preventing the edges of the tip sections from coming into contact with the inside surface of the delivery sheath can be realized. Alternatively or in addition to the goal of reducing friction, placement of inflatable material on various areas on a surface of the catheter could act to remove clots and/or fibrin through the inflation thereof (i.e., by knocking the formations off of the surface upon inflation). Referring now to
In yet another embodiment of the present invention, a friction reducing structure is provided by positioning a ridge or ridges 380 on the inside surface 372 of delivery sheath 370, as shown in
It is noted that although the delivery problems presented with reference to
Referring now to
The creation of an increasing separation force between tip sections can be accomplished in a variety of ways, as one of skill in the art should appreciate, some of which ways will be described in detail below (though certainly many others would be within the scope of the present invention). In addition, although the examples herein are described with respect to an increasing separation force, the production of a decreasing separation force is also contemplated, the implementation of which should be apparent to one of skill in the art in light of the discussion regarding an increasing separation force. Further, the discussion with respect to the separation of splittable tip sections herein encompasses both permanent and temporary (i.e., releasably joined) separation.
The concept of increasing the required separation force to separate tip sections from one another is illustrated by way of example, not limitation, through the graphs in
The graphs in F is too great for spontaneous splitting.
One embodiment of tip sections having an increasing separation force is illustrated in
As shown in
In addition to greater bond strength for the fusion points in adjacent zones in
Yet another embodiment of the present invention with respect to the establishment of an increasing separation force is illustrated in
A further embodiment of a catheter having a variable separation force is illustrated in
Methods for producing the desired effects with respect to the establishment of an increasing separation force, as described above, include (but are not limited to) utilizing constant separation stress with a variable area and using a variable separation stress with a constant area. Realization of these embodiments can be accomplished through many different bonding techniques, a few of which are described below.
With respect to constant separation stress over a variable area, a first potential technique is the use of adhesive bonding in creating a varying pattern of adhesive to join the tip sections of a split-tip catheter. Types of adhesive which could be used include epoxy and cyanoacrylates, although certainly other comparable adhesives would also be suitable. This idea has been explored above, for example, with respect to varying the density of the fusion points and the size of the fusion points. A second technique is the use of solvent bonding in creating a varying pattern of solvent to join the tip sections of a split-tip catheter. Examples of the types of solvents that could be employed include Tecoflex® 1-MP (Thermedics), methyl ethyl ketone (MEK), cyclohexanon and alcohol, though certainly others could be used. A third technique is the use of thermal welding, in which heat can be used to join the tip sections of a split-tip catheter. A fourth technique is the use of RF energy to fuse the tip sections of a split-tip catheter. Finally, a fifth technique is the use of variable extrusion where surface area of a joining web could be increased between two lumens during the extrusion process.
In reference to variable separation stress over a constant area, the techniques above would be applicable in a different way. Specifically, in an adhesive bonding technique, the concentration of the adhesive could be varied to produce the variable bond strength. This idea has been explored above with respect to varying the type of adhesive used. In a solvent bonding technique, the solvent could be varied or the pressure utilized to join the tip sections could be varied. In a thermal welding technique, the temperature or dwell time could be varied. In an RF fusion technique, variable RF energy could be utilized. Finally, in a variable extrusion technique, pressure, temperature or dwell time could be varied during the extrusion process.
Still another embodiment of the present invention with respect to the establishment of an increasing separation force is illustrated in
The twisting action can be implemented in a number of ways, including employing a mandrel having a desired twist, which when inserted into a still warm tube, imparts the twist to the tube during cooling and utilizing a series of mandrels to force a previously straight tube into a desired twisted pattern, wherein heat is applied to reset the tubing configuration. Another technique would be to employ an extrusion die having a preset desired twist so that the twist is imparted to the catheter during formation thereof. Referring back to
Although improvements to the functioning and usability of a split-tip catheter have been presented separately herein, the improvements described above (for example, openings positioned near a dividing point of a split tip catheter, positioning of a guidewire aperture in a venous tip section, configuration of arterial and venous tip sections with respect to one another, friction reducing structures provided on a delivery sheath and/or a catheter, varying the separation force required to separate tip sections from one another, etc.) should not be considered exclusive and instead should be considered for use in conjunction with one another.
The present invention has been described above in terms of certain preferred embodiments so that an understanding of the present invention can be conveyed. However, there are many alternative arrangements for a multi-lumen catheter not specifically described herein but with which the present invention is applicable. Although specific features have been provided, the multi-lumen catheter of the present invention would equally be embodied by other configurations not specifically recited herein. The scope of the present invention should therefore not be limited by the embodiments illustrated, but rather it should be understood that the present invention has wide applicability with respect to catheter systems generally. All modifications, variations, or equivalent elements and implementations that are within the scope of the appended claims should therefore be considered within the scope of the invention.
This application is a continuation of U.S. patent application Ser. No. 11/874,447, filed Oct. 18, 2007, now U.S. Pat. No. 8,808,227, which is a continuation of U.S. patent application Ser. No. 10/371,774, filed Feb. 21, 2003, now U.S. Pat. No. 7,393,339, each of which is incorporated by reference into this application as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
701075 | McCully | May 1902 | A |
1696018 | Scheliberg | Dec 1928 | A |
1856811 | Inaki | May 1932 | A |
2024982 | Scott | Dec 1935 | A |
2173527 | Agayoff | Sep 1939 | A |
2286462 | Chaffin | Jun 1942 | A |
2393002 | Smith | Jan 1946 | A |
2748769 | Huber | Jun 1956 | A |
2910981 | Wilson et al. | Nov 1959 | A |
3144868 | Jascalevich | Aug 1964 | A |
3176690 | H'Doubler | Apr 1965 | A |
3256885 | Higgins et al. | Jun 1966 | A |
3308822 | De Luca | Mar 1967 | A |
3416532 | Grossman | Dec 1968 | A |
3426759 | Smith | Feb 1969 | A |
3460255 | Hutson | Aug 1969 | A |
D217795 | Spaven | Jun 1970 | S |
3612038 | Halligan | Oct 1971 | A |
3736939 | Taylor | Jun 1973 | A |
3805794 | Schlesinger | Apr 1974 | A |
3812851 | Rodriguez | May 1974 | A |
3848604 | Sackner | Nov 1974 | A |
3890977 | Wilson | Jun 1975 | A |
3929126 | Corsaut | Dec 1975 | A |
3935857 | Co | Feb 1976 | A |
3995623 | Blake et al. | Dec 1976 | A |
4068659 | Moorehead | Jan 1978 | A |
4072146 | Howes | Feb 1978 | A |
4072153 | Swartz | Feb 1978 | A |
4098275 | Consalvo | Jul 1978 | A |
4114625 | Onat | Sep 1978 | A |
4117836 | Erikson | Oct 1978 | A |
4129129 | Amrine | Dec 1978 | A |
4134402 | Mahurkar | Jan 1979 | A |
4149535 | Volder et al. | Apr 1979 | A |
4180068 | Jacobsen et al. | Dec 1979 | A |
D254444 | Levine | Mar 1980 | S |
4248224 | Jones | Feb 1981 | A |
4276880 | Malmin | Jul 1981 | A |
4292976 | Banka | Oct 1981 | A |
4299228 | Peters | Nov 1981 | A |
4300550 | Gandi et al. | Nov 1981 | A |
4309994 | Grunwald | Jan 1982 | A |
4327722 | Groshong et al. | May 1982 | A |
4385631 | Uthmann et al. | May 1983 | A |
4392855 | Oreopoulos et al. | Jul 1983 | A |
4403983 | Edelman et al. | Sep 1983 | A |
4405313 | Sisley et al. | Sep 1983 | A |
4406656 | Hattler et al. | Sep 1983 | A |
D272651 | Mahurkar | Feb 1984 | S |
4431426 | Groshong et al. | Feb 1984 | A |
4432722 | Bohan, Jr. et al. | Feb 1984 | A |
4432752 | Marlon | Feb 1984 | A |
4445893 | Bodicky | May 1984 | A |
4451252 | Martin et al. | May 1984 | A |
4453928 | Steiger | Jun 1984 | A |
4465482 | Tittel et al. | Aug 1984 | A |
4490138 | Lipsky et al. | Dec 1984 | A |
4493696 | Uldall et al. | Jan 1985 | A |
RE31873 | Howes | Apr 1985 | E |
4531933 | Norton et al. | Jul 1985 | A |
4543087 | Sommercorn et al. | Sep 1985 | A |
4545373 | Christoudias | Oct 1985 | A |
4549879 | Groshong et al. | Oct 1985 | A |
4557261 | Rugheimer et al. | Dec 1985 | A |
4568329 | Mahurkar | Feb 1986 | A |
4568338 | Todd | Feb 1986 | A |
4573476 | Ruiz | Mar 1986 | A |
4581012 | Brown et al. | Apr 1986 | A |
4583968 | Mahurkar | Apr 1986 | A |
4583986 | Lapidus | Apr 1986 | A |
4601697 | Mammolenti et al. | Jul 1986 | A |
4619643 | Bai | Oct 1986 | A |
4623327 | Mahurkar | Nov 1986 | A |
4626240 | Edelman et al. | Dec 1986 | A |
4642101 | Krolikowski et al. | Feb 1987 | A |
4643711 | Bates | Feb 1987 | A |
4666426 | Aigner et al. | May 1987 | A |
4668221 | Luther | May 1987 | A |
4670009 | Bullock | Jun 1987 | A |
4675004 | Hadford et al. | Jun 1987 | A |
4681122 | Winters et al. | Jul 1987 | A |
4681564 | Landreneau | Jul 1987 | A |
4681570 | Dalton | Jul 1987 | A |
4682978 | Martin et al. | Jul 1987 | A |
4687471 | Twardowski et al. | Aug 1987 | A |
4692141 | Mahurkar | Sep 1987 | A |
4694838 | Wijayarthna et al. | Sep 1987 | A |
4701159 | Brown et al. | Oct 1987 | A |
4702917 | Schindler | Oct 1987 | A |
4713171 | Polaschegg | Dec 1987 | A |
4717379 | Ekholmer et al. | Jan 1988 | A |
4735620 | Ruiz | Apr 1988 | A |
4737141 | Spits et al. | Apr 1988 | A |
4737152 | Alchas | Apr 1988 | A |
4738667 | Galloway | Apr 1988 | A |
4748808 | Hill | Jun 1988 | A |
4755176 | Patel | Jul 1988 | A |
4769016 | Labianca | Sep 1988 | A |
4770652 | Mahurkar | Sep 1988 | A |
4772268 | Bates | Sep 1988 | A |
4772269 | Twardowski et al. | Sep 1988 | A |
4776841 | Catalano | Oct 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4784638 | Ghajar et al. | Nov 1988 | A |
4790809 | Kuntz | Dec 1988 | A |
4795439 | Guest | Jan 1989 | A |
4801297 | Mueller | Jan 1989 | A |
D300060 | Molgaard-Nielsen | Feb 1989 | S |
4804359 | Grunwald et al. | Feb 1989 | A |
4808155 | Mahurkar | Feb 1989 | A |
4808163 | Laub | Feb 1989 | A |
4809710 | Williamson | Mar 1989 | A |
4820265 | DeSatnick et al. | Apr 1989 | A |
4832687 | Smith, III | May 1989 | A |
4834709 | Banning et al. | May 1989 | A |
4842582 | Mahurkar | Jun 1989 | A |
4842592 | Caggiani et al. | Jun 1989 | A |
4846814 | Ruiz | Jul 1989 | A |
4863441 | Lindsay et al. | Sep 1989 | A |
4867742 | Calderon | Sep 1989 | A |
4892518 | Cupp et al. | Jan 1990 | A |
4894057 | Howes | Jan 1990 | A |
4895561 | Mahurkar | Jan 1990 | A |
4898591 | Jang et al. | Feb 1990 | A |
4906238 | Greenfeld et al. | Mar 1990 | A |
4925452 | Melinyshyn et al. | May 1990 | A |
4927418 | Dake et al. | May 1990 | A |
4935004 | Cruz | Jun 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4935044 | Schoenpflug et al. | Jun 1990 | A |
4936826 | Amarasinghe | Jun 1990 | A |
4950232 | Ruzicka et al. | Aug 1990 | A |
4950259 | Geary et al. | Aug 1990 | A |
4951665 | Schneider | Aug 1990 | A |
4961729 | Vaillancourt | Oct 1990 | A |
4961731 | Bodicky et al. | Oct 1990 | A |
4961809 | Martin et al. | Oct 1990 | A |
4968307 | Dake et al. | Nov 1990 | A |
4969890 | Sugita et al. | Nov 1990 | A |
4981477 | Schon et al. | Jan 1991 | A |
4985014 | Orejola | Jan 1991 | A |
4990138 | Bacich | Feb 1991 | A |
4994027 | Farrell | Feb 1991 | A |
4995865 | Gahara et al. | Feb 1991 | A |
5009636 | Wortley et al. | Apr 1991 | A |
5015230 | Martin et al. | May 1991 | A |
5016640 | Ruiz | May 1991 | A |
5021044 | Sharkawy | Jun 1991 | A |
5041101 | Seder et al. | Aug 1991 | A |
5041107 | Heil, Jr. | Aug 1991 | A |
5049138 | Chevalier et al. | Sep 1991 | A |
5053003 | Dadson et al. | Oct 1991 | A |
5053004 | Markel et al. | Oct 1991 | A |
5053023 | Martin | Oct 1991 | A |
5057073 | Martin | Oct 1991 | A |
5059170 | Cameron | Oct 1991 | A |
5069673 | Shwab | Dec 1991 | A |
5074841 | Ademovic et al. | Dec 1991 | A |
5084013 | Takase et al. | Jan 1992 | A |
5098412 | Shiu et al. | Mar 1992 | A |
5100395 | Rosenberg et al. | Mar 1992 | A |
5102402 | Dror et al. | Apr 1992 | A |
5106368 | Uldall et al. | Apr 1992 | A |
5106376 | Mononen et al. | Apr 1992 | A |
5111829 | Alvarez de Toledo | May 1992 | A |
5112301 | Fenton, Jr. et al. | May 1992 | A |
5114423 | Kasprzyk et al. | May 1992 | A |
5117836 | Millar | Jun 1992 | A |
5120299 | Lombardi | Jun 1992 | A |
5120304 | Sasaki | Jun 1992 | A |
5122125 | Deuss et al. | Jun 1992 | A |
5125904 | Lee | Jun 1992 | A |
5129891 | Young | Jul 1992 | A |
5135599 | Martin et al. | Aug 1992 | A |
5139486 | Moss | Aug 1992 | A |
5156592 | Martin et al. | Oct 1992 | A |
5163928 | Hobbs et al. | Nov 1992 | A |
5167623 | Cianci et al. | Dec 1992 | A |
5171216 | Dasse et al. | Dec 1992 | A |
5171227 | Twardowski et al. | Dec 1992 | A |
5178616 | Uemiya et al. | Jan 1993 | A |
5188592 | Hakki | Feb 1993 | A |
5188593 | Martin | Feb 1993 | A |
5190520 | Fenton, Jr. et al. | Mar 1993 | A |
5190529 | McCrory et al. | Mar 1993 | A |
5191898 | Millar | Mar 1993 | A |
5195962 | Martin et al. | Mar 1993 | A |
5197951 | Mahurkar | Mar 1993 | A |
5197973 | Pang et al. | Mar 1993 | A |
5197976 | Herweck et al. | Mar 1993 | A |
5201723 | Quinn | Apr 1993 | A |
5207648 | Gross | May 1993 | A |
5207650 | Martin | May 1993 | A |
5209723 | Twardowski et al. | May 1993 | A |
5209725 | Roth | May 1993 | A |
5209742 | Venema et al. | May 1993 | A |
5215527 | Beck et al. | Jun 1993 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5221256 | Mahurkar | Jun 1993 | A |
5222949 | Kaldany | Jun 1993 | A |
5226880 | Martin et al. | Jul 1993 | A |
5234438 | Semrad | Aug 1993 | A |
5236016 | Vogelsang et al. | Aug 1993 | A |
5242398 | Knoll et al. | Sep 1993 | A |
5246430 | MacFarlane | Sep 1993 | A |
5250034 | Appling et al. | Oct 1993 | A |
5254084 | Geary | Oct 1993 | A |
5273527 | Schatz et al. | Dec 1993 | A |
5273534 | Knoepfler | Dec 1993 | A |
5279596 | Castaneda et al. | Jan 1994 | A |
5279599 | Wilk | Jan 1994 | A |
5306240 | Berry | Apr 1994 | A |
5312337 | Flaherty et al. | May 1994 | A |
5312357 | Buijs et al. | May 1994 | A |
5318517 | Reiman | Jun 1994 | A |
5322519 | Ash | Jun 1994 | A |
5324274 | Martin | Jun 1994 | A |
5330432 | Yoon | Jul 1994 | A |
5338308 | Wilk | Aug 1994 | A |
5342295 | Imran | Aug 1994 | A |
5342386 | Trotta | Aug 1994 | A |
5346471 | Raulerson | Sep 1994 | A |
5348536 | Young et al. | Sep 1994 | A |
5350358 | Martin | Sep 1994 | A |
5360397 | Pinchuk | Nov 1994 | A |
5360407 | Leonard et al. | Nov 1994 | A |
5364344 | Beattie et al. | Nov 1994 | A |
5374245 | Mahurkar | Dec 1994 | A |
5378230 | Mahurkar | Jan 1995 | A |
5380276 | Miller et al. | Jan 1995 | A |
5380290 | Makower et al. | Jan 1995 | A |
5382238 | Abrahamson et al. | Jan 1995 | A |
5389087 | Miraki | Feb 1995 | A |
5389090 | Fischell et al. | Feb 1995 | A |
5395316 | Martin et al. | Mar 1995 | A |
5399168 | Wadsworth, Jr. et al. | Mar 1995 | A |
5403291 | Abrahamson | Apr 1995 | A |
5405320 | Twardowski et al. | Apr 1995 | A |
5405341 | Martin | Apr 1995 | A |
5409463 | Thomas et al. | Apr 1995 | A |
5417668 | Setzer et al. | May 1995 | A |
5423768 | Folden et al. | Jun 1995 | A |
5431661 | Koch | Jul 1995 | A |
5451026 | Smith | Sep 1995 | A |
5451206 | Young | Sep 1995 | A |
5451233 | Yock | Sep 1995 | A |
5458570 | May, Jr. | Oct 1995 | A |
5458582 | Nakao | Oct 1995 | A |
5462533 | Daugherty | Oct 1995 | A |
5472417 | Martin et al. | Dec 1995 | A |
5472432 | Martin | Dec 1995 | A |
5476453 | Mehta | Dec 1995 | A |
5480380 | Martin | Jan 1996 | A |
5486159 | Mahurkar | Jan 1996 | A |
5489278 | Abrahamson | Feb 1996 | A |
5496292 | Burnham | Mar 1996 | A |
5496872 | Constancis et al. | Mar 1996 | A |
5505710 | Dorsey, III | Apr 1996 | A |
5507723 | Keshaviah | Apr 1996 | A |
5509897 | Twardowski et al. | Apr 1996 | A |
5509900 | Kirkman | Apr 1996 | A |
5509902 | Raulerson | Apr 1996 | A |
5542925 | Orth | Aug 1996 | A |
5545373 | Maziasz et al. | Aug 1996 | A |
5556390 | Hicks | Sep 1996 | A |
5556930 | Brehm et al. | Sep 1996 | A |
5558635 | Cannon | Sep 1996 | A |
5562609 | Brumbach | Oct 1996 | A |
5562696 | Nobles et al. | Oct 1996 | A |
5569182 | Twardowski et al. | Oct 1996 | A |
5569195 | Saab | Oct 1996 | A |
5571093 | Cruz et al. | Nov 1996 | A |
5584803 | Stevens et al. | Dec 1996 | A |
5599304 | Shaari | Feb 1997 | A |
5599328 | Stevens | Feb 1997 | A |
5607462 | Imran | Mar 1997 | A |
5624392 | Saab | Apr 1997 | A |
5624413 | Markel et al. | Apr 1997 | A |
5632729 | Cai et al. | May 1997 | A |
5637102 | Tolkoff et al. | Jun 1997 | A |
5642270 | Green et al. | Jun 1997 | A |
5655867 | Gysi et al. | Aug 1997 | A |
5662606 | Cimino et al. | Sep 1997 | A |
5665067 | Linder et al. | Sep 1997 | A |
5674237 | Ott | Oct 1997 | A |
5685867 | Twardowski et al. | Nov 1997 | A |
5686867 | Sutardja et al. | Nov 1997 | A |
5693030 | Lee et al. | Dec 1997 | A |
5695457 | St. Goar et al. | Dec 1997 | A |
5704915 | Melsky et al. | Jan 1998 | A |
5713849 | Bosma et al. | Feb 1998 | A |
5713853 | Clark et al. | Feb 1998 | A |
5717216 | McCoy et al. | Feb 1998 | A |
5718678 | Fleming, III | Feb 1998 | A |
5718692 | Schon et al. | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5738649 | Macoviak | Apr 1998 | A |
5741329 | Agrawal et al. | Apr 1998 | A |
5743873 | Cai et al. | Apr 1998 | A |
5752939 | Makoto | May 1998 | A |
5769796 | Palermo et al. | Jun 1998 | A |
5772643 | Howell et al. | Jun 1998 | A |
5776096 | Fields | Jul 1998 | A |
5776111 | Tesio | Jul 1998 | A |
5785686 | Runge | Jul 1998 | A |
5792094 | Stevens et al. | Aug 1998 | A |
5792123 | Ensminger | Aug 1998 | A |
5797869 | Martin et al. | Aug 1998 | A |
5800384 | Russell et al. | Sep 1998 | A |
5800414 | Cazal et al. | Sep 1998 | A |
5800516 | Fine et al. | Sep 1998 | A |
5807311 | Palestrant | Sep 1998 | A |
5807318 | St. Goar et al. | Sep 1998 | A |
5807329 | Gelman | Sep 1998 | A |
5809897 | Powell et al. | Sep 1998 | A |
5810789 | Powers et al. | Sep 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5830184 | Basta | Nov 1998 | A |
5830196 | Hicks | Nov 1998 | A |
5833671 | Macoviak et al. | Nov 1998 | A |
5843048 | Gross | Dec 1998 | A |
5858009 | Jonkman | Jan 1999 | A |
5861010 | Boussignac et al. | Jan 1999 | A |
5868717 | Prosl | Feb 1999 | A |
5873865 | Horzewski et al. | Feb 1999 | A |
5876366 | Dykstra et al. | Mar 1999 | A |
5876426 | Kume et al. | Mar 1999 | A |
5882347 | Mouris-Laan et al. | Mar 1999 | A |
5891111 | Ismael et al. | Apr 1999 | A |
5904670 | Schreiner | May 1999 | A |
5911715 | Berg et al. | Jun 1999 | A |
5913848 | Luther et al. | Jun 1999 | A |
5916208 | Luther et al. | Jun 1999 | A |
5919160 | Sanfilippo, II | Jul 1999 | A |
5944732 | Raulerson et al. | Aug 1999 | A |
5947937 | Urrutia et al. | Sep 1999 | A |
5947953 | Ash et al. | Sep 1999 | A |
5957879 | Roberts et al. | Sep 1999 | A |
5957893 | Luther et al. | Sep 1999 | A |
5957912 | Heitzmann | Sep 1999 | A |
5961486 | Twardowski et al. | Oct 1999 | A |
5964796 | Imran | Oct 1999 | A |
5976103 | Martin | Nov 1999 | A |
5976120 | Chow et al. | Nov 1999 | A |
5980551 | Summers et al. | Nov 1999 | A |
5984908 | Davis et al. | Nov 1999 | A |
5989206 | Prosl et al. | Nov 1999 | A |
5989213 | Maginot | Nov 1999 | A |
6001079 | Pourchez | Dec 1999 | A |
6033382 | Basta | Mar 2000 | A |
6036654 | Quinn et al. | Mar 2000 | A |
6059771 | Balbierz et al. | May 2000 | A |
6074374 | Fulton | Jun 2000 | A |
6086555 | Eliasen et al. | Jul 2000 | A |
6090096 | St. Goar et al. | Jul 2000 | A |
6099513 | Spehalski | Aug 2000 | A |
6103778 | Hyon et al. | Aug 2000 | A |
6106540 | White et al. | Aug 2000 | A |
6113572 | Gailey et al. | Sep 2000 | A |
6117117 | Mauch | Sep 2000 | A |
6120494 | Jonkman | Sep 2000 | A |
6126631 | Loggie | Oct 2000 | A |
6143013 | Samson | Nov 2000 | A |
6146354 | Beil | Nov 2000 | A |
6146373 | Cragg et al. | Nov 2000 | A |
6152909 | Bagaoisan et al. | Nov 2000 | A |
6156016 | Maginot | Dec 2000 | A |
6161547 | Barbut | Dec 2000 | A |
6178356 | Chastain et al. | Jan 2001 | B1 |
6180059 | Divino, Jr. et al. | Jan 2001 | B1 |
6190349 | Ash | Feb 2001 | B1 |
6190371 | Maginot et al. | Feb 2001 | B1 |
6193685 | Goodin | Feb 2001 | B1 |
6196996 | Teirstein | Mar 2001 | B1 |
6206849 | Martin et al. | Mar 2001 | B1 |
6210365 | Afzal | Apr 2001 | B1 |
6210380 | Mauch | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6224622 | Kotzev | May 2001 | B1 |
6238406 | Ellis et al. | May 2001 | B1 |
6264627 | Liska et al. | Jul 2001 | B1 |
6273879 | Keith et al. | Aug 2001 | B1 |
6280413 | Clark et al. | Aug 2001 | B1 |
6280423 | Davey et al. | Aug 2001 | B1 |
6287326 | Pecor | Sep 2001 | B1 |
6293927 | McGuckin, Jr. | Sep 2001 | B1 |
6293958 | Berry et al. | Sep 2001 | B1 |
6296631 | Chow | Oct 2001 | B2 |
6299631 | Shalaby | Oct 2001 | B1 |
6322551 | Brugger | Nov 2001 | B1 |
6328730 | Harkrider, Jr. | Dec 2001 | B1 |
6342120 | Basta | Jan 2002 | B1 |
6361529 | Goodin et al. | Mar 2002 | B1 |
6383172 | Barbut | May 2002 | B1 |
6394141 | Wages et al. | May 2002 | B2 |
6394142 | Woelfel et al. | May 2002 | B1 |
6409700 | Siegel, Jr. et al. | Jun 2002 | B1 |
6413228 | Hung et al. | Jul 2002 | B1 |
6428513 | Abrahamson | Aug 2002 | B1 |
6443922 | Roberts et al. | Sep 2002 | B1 |
6450988 | Bradshaw | Sep 2002 | B1 |
6453185 | O'Keefe | Sep 2002 | B1 |
6454997 | Divino, Jr. et al. | Sep 2002 | B1 |
6463335 | Munch et al. | Oct 2002 | B1 |
6468287 | Baugh | Oct 2002 | B1 |
6475207 | Maginot et al. | Nov 2002 | B1 |
6475209 | Larson et al. | Nov 2002 | B1 |
6478789 | Spehalski et al. | Nov 2002 | B1 |
6482169 | Kuhle | Nov 2002 | B1 |
6533763 | Schneiter | Mar 2003 | B1 |
6565594 | Herweck et al. | May 2003 | B1 |
6576001 | Werneth et al. | Jun 2003 | B2 |
6582459 | Lau et al. | Jun 2003 | B1 |
6585705 | Maginot et al. | Jul 2003 | B1 |
6592565 | Twardowski | Jul 2003 | B2 |
6595966 | Davey et al. | Jul 2003 | B2 |
6620118 | Prosl et al. | Sep 2003 | B1 |
6638242 | Wilson et al. | Oct 2003 | B2 |
6659134 | Navis | Dec 2003 | B2 |
6682498 | Ross | Jan 2004 | B2 |
6682519 | Schon | Jan 2004 | B1 |
6691625 | Duncan | Feb 2004 | B2 |
6695832 | Schon et al. | Feb 2004 | B2 |
6702776 | Quinn | Mar 2004 | B2 |
6712797 | Southern, Jr. | Mar 2004 | B1 |
6712798 | Constantz | Mar 2004 | B2 |
6719717 | Johnson et al. | Apr 2004 | B1 |
6719749 | Schweikert et al. | Apr 2004 | B1 |
6723084 | Maginot et al. | Apr 2004 | B1 |
6723114 | Shalaby | Apr 2004 | B2 |
6730299 | Tayot et al. | May 2004 | B1 |
6752827 | Ross et al. | Jun 2004 | B2 |
6755851 | Noda et al. | Jun 2004 | B2 |
6758836 | Zawacki | Jul 2004 | B2 |
6786664 | Claramunt et al. | Sep 2004 | B2 |
6786884 | DeCant, Jr. et al. | Sep 2004 | B1 |
6796991 | Nardeo | Sep 2004 | B2 |
6797107 | Kotzey | Sep 2004 | B1 |
6808510 | DiFiore | Oct 2004 | B1 |
6814718 | McGuckin, Jr. et al. | Nov 2004 | B2 |
6819951 | Patel et al. | Nov 2004 | B2 |
6821287 | Jang | Nov 2004 | B1 |
6824554 | Jang | Nov 2004 | B1 |
6835452 | Hamerski | Dec 2004 | B1 |
6837864 | Bertolero et al. | Jan 2005 | B1 |
6852079 | Miyano | Feb 2005 | B2 |
6852097 | Fulton, III | Feb 2005 | B1 |
6858019 | McGuckin, Jr. et al. | Feb 2005 | B2 |
6872198 | Wilson et al. | Mar 2005 | B1 |
6878143 | Andersen | Apr 2005 | B2 |
6881211 | Schweikert et al. | Apr 2005 | B2 |
6884253 | McFarlane | Apr 2005 | B1 |
6911014 | Wentling et al. | Jun 2005 | B2 |
6913601 | St. Goar et al. | Jul 2005 | B2 |
6916313 | Cunningham | Jul 2005 | B2 |
6921396 | Wilson et al. | Jul 2005 | B1 |
6921411 | Yock | Jul 2005 | B2 |
6934142 | Grosse et al. | Aug 2005 | B2 |
6966886 | Appling | Nov 2005 | B2 |
6969381 | Voorhees | Nov 2005 | B2 |
6979318 | McDonald et al. | Dec 2005 | B1 |
6991625 | Gately et al. | Jan 2006 | B1 |
D515211 | Chesnin | Feb 2006 | S |
6997894 | Caresio | Feb 2006 | B2 |
7008395 | Loggie | Mar 2006 | B1 |
7011645 | McGuckin, Jr. et al. | Mar 2006 | B2 |
7018384 | Skakoon | Mar 2006 | B2 |
7029467 | Currier et al. | Apr 2006 | B2 |
7066914 | Andersen | Jun 2006 | B2 |
7066925 | Gately et al. | Jun 2006 | B2 |
7074213 | McGuckin, Jr. et al. | Jul 2006 | B2 |
7077829 | McGuckin, Jr. et al. | Jul 2006 | B2 |
7087053 | Vanney | Aug 2006 | B2 |
7090654 | Lotito et al. | Aug 2006 | B2 |
7108674 | Quinn | Sep 2006 | B2 |
D530420 | Chesnin | Oct 2006 | S |
7128734 | Wilson et al. | Oct 2006 | B1 |
7130700 | Gardeski et al. | Oct 2006 | B2 |
7141035 | Haggstrom | Nov 2006 | B2 |
RE39451 | Kuhle | Dec 2006 | E |
7182746 | Haarala et al. | Feb 2007 | B2 |
7300430 | Wilson et al. | Nov 2007 | B2 |
7322953 | Redinger | Jan 2008 | B2 |
7347852 | Hobbs et al. | Mar 2008 | B2 |
7381204 | Wilson et al. | Jun 2008 | B2 |
7393339 | Zawacki et al. | Jul 2008 | B2 |
7422571 | Schweikert et al. | Sep 2008 | B2 |
7465286 | Patterson et al. | Dec 2008 | B2 |
7485107 | DiFiore et al. | Feb 2009 | B2 |
7569029 | Clark | Aug 2009 | B2 |
7575563 | Appling | Aug 2009 | B2 |
7651482 | Harris | Jan 2010 | B2 |
7686823 | Pingleton et al. | Mar 2010 | B2 |
7798999 | Bailey et al. | Sep 2010 | B2 |
7972465 | Patterson et al. | Jul 2011 | B2 |
8021321 | Zawacki | Sep 2011 | B2 |
8066660 | Gregersen et al. | Nov 2011 | B2 |
8092415 | Moehle | Jan 2012 | B2 |
8100863 | Moehle et al. | Jan 2012 | B2 |
8152951 | Zawacki et al. | Apr 2012 | B2 |
8206371 | Nimkar et al. | Jun 2012 | B2 |
8292841 | Gregersen | Oct 2012 | B2 |
8500939 | Nimkar et al. | Aug 2013 | B2 |
8540661 | Gregersen | Sep 2013 | B2 |
8597275 | Nimkar et al. | Dec 2013 | B2 |
8696614 | Gregersen et al. | Apr 2014 | B2 |
8808227 | Zawacki et al. | Aug 2014 | B2 |
8894601 | Moehle et al. | Nov 2014 | B2 |
8992454 | Anand | Mar 2015 | B2 |
20010041857 | Sansoucy | Nov 2001 | A1 |
20010041873 | Dopper et al. | Nov 2001 | A1 |
20020013569 | Sterman et al. | Jan 2002 | A1 |
20020026156 | Quinn | Feb 2002 | A1 |
20020086047 | Mueller et al. | Jul 2002 | A1 |
20020087108 | Maginot et al. | Jul 2002 | A1 |
20020087145 | Ehwald et al. | Jul 2002 | A1 |
20020091362 | Maginot et al. | Jul 2002 | A1 |
20020091430 | Dobak et al. | Jul 2002 | A1 |
20020099326 | Wilson | Jul 2002 | A1 |
20020099327 | Wilson et al. | Jul 2002 | A1 |
20020107506 | McGuckin et al. | Aug 2002 | A1 |
20020138031 | Ross | Sep 2002 | A1 |
20020169490 | Noda et al. | Nov 2002 | A1 |
20020177904 | Huxel et al. | Nov 2002 | A1 |
20030023198 | Twardowski | Jan 2003 | A1 |
20030088213 | Schweikert et al. | May 2003 | A1 |
20030093027 | McGuckin et al. | May 2003 | A1 |
20030097091 | Hobbs et al. | May 2003 | A1 |
20030144623 | Heath et al. | Jul 2003 | A1 |
20030149395 | Zawacki | Aug 2003 | A1 |
20030153898 | Schon et al. | Aug 2003 | A1 |
20030187411 | Constantz | Oct 2003 | A1 |
20030204179 | Davey et al. | Oct 2003 | A1 |
20040039350 | McKittrick | Feb 2004 | A1 |
20040054321 | Schon et al. | Mar 2004 | A1 |
20040059314 | Schon et al. | Mar 2004 | A1 |
20040064086 | Gottlieb et al. | Apr 2004 | A1 |
20040065333 | Wilson et al. | Apr 2004 | A1 |
20040075198 | Schweikert et al. | Apr 2004 | A1 |
20040087892 | Cunningham | May 2004 | A1 |
20040092863 | Raulerson et al. | May 2004 | A1 |
20040097863 | Appling | May 2004 | A1 |
20040097903 | Raulerson | May 2004 | A1 |
20040122418 | Voorhees | Jun 2004 | A1 |
20040147903 | Latini | Jul 2004 | A1 |
20040167463 | Zawacki et al. | Aug 2004 | A1 |
20040171997 | Wilson et al. | Sep 2004 | A1 |
20040172003 | Wilson et al. | Sep 2004 | A1 |
20040176739 | Stephens et al. | Sep 2004 | A1 |
20040193102 | Haggstrom | Sep 2004 | A1 |
20040210180 | Altman | Oct 2004 | A1 |
20040210187 | Zawacki | Oct 2004 | A1 |
20040210237 | Ross et al. | Oct 2004 | A1 |
20040220550 | Schryver | Nov 2004 | A1 |
20040230204 | Wortley et al. | Nov 2004 | A1 |
20040243095 | Nimkar et al. | Dec 2004 | A1 |
20040249337 | DiFiore | Dec 2004 | A1 |
20050003322 | Logan et al. | Jan 2005 | A1 |
20050004504 | Frye et al. | Jan 2005 | A1 |
20050013341 | Baghai | Jan 2005 | A1 |
20050025641 | Shibata et al. | Feb 2005 | A1 |
20050027282 | Schweikert et al. | Feb 2005 | A1 |
20050027289 | Castellano et al. | Feb 2005 | A1 |
20050033222 | Haggstrom et al. | Feb 2005 | A1 |
20050033264 | Redinger | Feb 2005 | A1 |
20050054989 | McGuckin et al. | Mar 2005 | A1 |
20050055012 | Trerotola | Mar 2005 | A1 |
20050059925 | Maginot et al. | Mar 2005 | A1 |
20050070842 | Lotito et al. | Mar 2005 | A1 |
20050080398 | Markel et al. | Apr 2005 | A1 |
20050085765 | Voorhees | Apr 2005 | A1 |
20050096585 | Schon et al. | May 2005 | A1 |
20050113904 | Shank et al. | May 2005 | A1 |
20050131341 | McGuckin et al. | Jun 2005 | A1 |
20050171469 | Cunningham | Aug 2005 | A1 |
20050187535 | Wilson et al. | Aug 2005 | A1 |
20050215977 | Uschold | Sep 2005 | A1 |
20050228339 | Clark | Oct 2005 | A1 |
20050245900 | Ash | Nov 2005 | A1 |
20050251190 | McFarlane | Nov 2005 | A1 |
20050256461 | DiFiore et al. | Nov 2005 | A1 |
20050261663 | Patterson et al. | Nov 2005 | A1 |
20050267400 | Haarala et al. | Dec 2005 | A1 |
20050277862 | Anand | Dec 2005 | A1 |
20050283111 | Maurice | Dec 2005 | A1 |
20050288623 | Hjalmarsson | Dec 2005 | A1 |
20050288706 | Widomski et al. | Dec 2005 | A1 |
20060004316 | Difiore et al. | Jan 2006 | A1 |
20060004325 | Hamatake et al. | Jan 2006 | A1 |
20060009783 | Rome et al. | Jan 2006 | A1 |
20060015072 | Raulerson | Jan 2006 | A1 |
20060015130 | Voorhees et al. | Jan 2006 | A1 |
20060030827 | Raulerson et al. | Feb 2006 | A1 |
20060047267 | Gately et al. | Mar 2006 | A1 |
20060047268 | Stephens | Mar 2006 | A1 |
20060058775 | Stevens et al. | Mar 2006 | A1 |
20060064072 | Gately et al. | Mar 2006 | A1 |
20060095062 | Stephens | May 2006 | A1 |
20060100572 | DiMatteo et al. | May 2006 | A1 |
20060161100 | Hamboly | Jul 2006 | A1 |
20060184142 | Schon et al. | Aug 2006 | A1 |
20060189922 | Amarasinghe et al. | Aug 2006 | A1 |
20060200111 | Moehle et al. | Sep 2006 | A1 |
20060206094 | Chesnin et al. | Sep 2006 | A1 |
20060251612 | Kotzev et al. | Nov 2006 | A1 |
20060253063 | Schweikert | Nov 2006 | A1 |
20060271012 | Canaud et al. | Nov 2006 | A1 |
20070005003 | Patterson et al. | Jan 2007 | A1 |
20070019181 | Sinclair et al. | Jan 2007 | A1 |
20070066964 | Atkins | Mar 2007 | A1 |
20070078478 | Atkins et al. | Apr 2007 | A1 |
20070106206 | Appling | May 2007 | A1 |
20070129704 | O'Mahony et al. | Jun 2007 | A1 |
20070167925 | Jacqmein | Jul 2007 | A1 |
20070191810 | Kennedy | Aug 2007 | A1 |
20070225661 | Ash et al. | Sep 2007 | A1 |
20070225682 | Ash et al. | Sep 2007 | A1 |
20070282274 | Chesnin | Dec 2007 | A1 |
20080021417 | Zawacki et al. | Jan 2008 | A1 |
20080039774 | Zawacki et al. | Feb 2008 | A1 |
20080065029 | Racz | Mar 2008 | A1 |
20080082079 | Braga et al. | Apr 2008 | A1 |
20080082080 | Braga | Apr 2008 | A1 |
20080097409 | Stephens | Apr 2008 | A1 |
20080172012 | Hiniduma-Lokuge et al. | Jul 2008 | A1 |
20080214980 | Anand | Sep 2008 | A1 |
20080214992 | Haarala et al. | Sep 2008 | A1 |
20090112153 | Gregersen et al. | Apr 2009 | A1 |
20090118661 | Moehle et al. | May 2009 | A1 |
20090118701 | Nimkar et al. | May 2009 | A1 |
20090118707 | Schweikert et al. | May 2009 | A1 |
20090118755 | Maliglowka et al. | May 2009 | A1 |
20090138034 | Maliglowka et al. | May 2009 | A1 |
20090157051 | Appling et al. | Jun 2009 | A1 |
20090187141 | Lareau et al. | Jul 2009 | A1 |
20090192435 | Gregersen | Jul 2009 | A1 |
20090204052 | Nimkar et al. | Aug 2009 | A1 |
20090204079 | Nimkar et al. | Aug 2009 | A1 |
20090204083 | O'Donnell et al. | Aug 2009 | A1 |
20090205189 | Nimkar et al. | Aug 2009 | A1 |
20090209940 | Nimkar et al. | Aug 2009 | A1 |
20090292248 | Schon et al. | Nov 2009 | A1 |
20100081986 | Matson et al. | Apr 2010 | A1 |
20100331780 | Bellisario et al. | Dec 2010 | A1 |
20110020418 | Bosley, Jr. et al. | Jan 2011 | A1 |
20120059304 | Gregersen et al. | Mar 2012 | A1 |
20120089070 | Moehle et al. | Apr 2012 | A1 |
20130018405 | Onishi et al. | Jan 2013 | A1 |
20130079752 | Gregersen | Mar 2013 | A1 |
20130253445 | Nimkar et al. | Sep 2013 | A1 |
20140025042 | Gregersen | Jan 2014 | A1 |
20140088510 | Nimkar et al. | Mar 2014 | A1 |
20140228742 | Gregersen et al. | Aug 2014 | A1 |
20140276472 | VanderStek et al. | Sep 2014 | A1 |
20140277052 | Haselby et al. | Sep 2014 | A1 |
20140336687 | Iwase et al. | Nov 2014 | A1 |
20150073336 | Moehle et al. | Mar 2015 | A1 |
20150088100 | Oborn et al. | Mar 2015 | A1 |
Number | Date | Country |
---|---|---|
834211 | Feb 1976 | BE |
1150122 | Jul 1983 | CA |
2474351 | Aug 2003 | CA |
2788836 | Jun 2006 | CN |
101918067 | Dec 2010 | CN |
201310073124 | Mar 2013 | CN |
103170050 | Jun 2013 | CN |
101918066 | Jul 2013 | CN |
8815869 | Feb 1989 | DE |
9108132 | Sep 1991 | DE |
102005051211 | May 2007 | DE |
0030854 | Jun 1981 | EP |
0132344 | Jan 1985 | EP |
0301854 | Feb 1989 | EP |
0332366 | Sep 1989 | EP |
0386408 | Sep 1990 | EP |
0453234 | Oct 1991 | EP |
0476796 | Mar 1992 | EP |
0495263 | Jul 1992 | EP |
0650740 | May 1995 | EP |
0711574 | May 1996 | EP |
1471966 | Nov 2004 | EP |
1599247 | Nov 2005 | EP |
1503469 | Mar 1978 | GB |
56-136569 | Oct 1981 | JP |
8-510935 | Nov 1996 | JP |
2001137350 | May 2001 | JP |
2008500081 | Jan 2008 | JP |
4827377 | Nov 2011 | JP |
459237 | Feb 1975 | SU |
9108132 | Jun 1991 | WO |
9316741 | Sep 1993 | WO |
9316752 | Sep 1993 | WO |
9709086 | Mar 1997 | WO |
9717102 | May 1997 | WO |
9722374 | Jun 1997 | WO |
9737699 | Oct 1997 | WO |
9904844 | Feb 1999 | WO |
0023137 | Apr 2000 | WO |
02058776 | Aug 2002 | WO |
02083223 | Oct 2002 | WO |
03030960 | Apr 2003 | WO |
03033049 | Apr 2003 | WO |
03066148 | Aug 2003 | WO |
04075962 | Sep 2004 | WO |
04096334 | Nov 2004 | WO |
04112876 | Dec 2004 | WO |
2005018712 | Mar 2005 | WO |
2005023336 | Mar 2005 | WO |
2005077449 | Aug 2005 | WO |
2005084741 | Sep 2005 | WO |
2005118039 | Dec 2005 | WO |
2006034877 | Apr 2006 | WO |
2009051967 | Apr 2009 | WO |
2009055332 | Apr 2009 | WO |
2009059220 | May 2009 | WO |
2015077560 | May 2015 | WO |
Entry |
---|
Haire, et al, Thrombotic Complications of Subclavian Apheresis catheters in Cancer Patients: Prevention With Heparin Infusion, Journal of Clinical Apheresis, 1990, vol. 5, pp. 188-191. |
Hull, et al., The Groshong Catheter: Initial Experience and Early Results of Imaging-guided Placementl, Radiology, 1992, vol. 185, pp. 803-807. |
Ignotus, et al., Review of Radiological Insertion of Indwelling Central Venous Catheters, Minimally Invasive Therapy, 1992, 1:373-388. |
Instructions for Use (Copyright Dated 1990) for Polycath Polyurethance Central Venous Catheter; believed to have been packaged with product and sold in the United States before Jan. 4, 2000 and with related marketing materials. |
Instructions for Use (Copyright Dated 1992) for FloLock Single Lumen Bi-directional Valved Catheter; believed to have been packaged with product and sold in the United States before Jan. 2000. |
Instructions for Use (not dated) for Infuse-a-Cath Polyurethance Central Venous Catheter; believed to have been packaged with product and sold in the United States before Jan. 2000. |
Instructions for Use for Diatek Cannon Catheter Product First Sold in the United States in Sep. 2001. |
Jones, et al., Efficacy of the Supraclavicular Route for Temporary Hemodialysis Access, Southern Medical Journal, 1992, vol. 85, No. 7, pp. 725-726. |
JP 2010-532299 filed Apr. 30, 2010 Official Action dated Apr. 23, 2012. |
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Decision of Refusal mailed Dec. 24, 2009. |
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Official Action mailed May 28, 2009. |
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Official Action mailed Nov. 7, 2008. |
Kapoian et al. Dialysis as Treatment of End-Stage Renal Disease, Chapter 5: Dialysis Access and Recirculation, © 1999. |
Kaupke, et al., Perforation of the Superior Vena Cava by a Subclavian Hemodialysis Catheter: early detection by angiography, The International Journal of Artificial Organs, 1992, vol. 15, No. 11, pp. 666-668. |
Kelber, et al., Factors Affecting Delivery of High-Efficiency Dialysis Using Temporary Vascular Access, American Journal of Kidney Diseases, 1993, vol. 22, No. 1, pp. 24-29. |
Lumsden, et al., Hemodialysis Access in the Pediatric Patient Population, The American Journal of Surgery, 1994, vol. 168, pp. 197. |
Lund, “Percutaneous Translumbar Inferior Vena Cava Cannulation and other Alternative Vascular Access Techniques” in Venous Interventional Radiology with Clinical Perspectives, Savader et al, eds. pp. 251-61, Apr. 10, 2000. |
Lund, et al., Percutaneous Translumbar Inferior Vena Cava Cannulation for Hemodialysis, American Journal of Kidney Diseases, 1995, vol. 25, No. 5, pp. 732-737. |
Maki, D., Pathogenesis, Prevention, and Management of Infections Due to Intravascular Devices Used for Infusion Therapy, in Infections Associated with Indwelling Medical Devices, Bisno et al, eds, American Society for Microbiology, 1989, pp. 161-177. |
Malviya et al., “Vascular Access in Gynecological Cancer Using the Groshong Right Atrial Catheter”, Gynecological Oncology. |
Mauro, et al., Radiologic Placement of Long-term Central Venous Catheters: A Review, JVIR, 1993, vol. 4, No. 1, pp. 127-137. |
McGee, et al, Accurate placement of central venous catheters: A prospective, randomized, multicenter trial, Critical Care Medicine, 1993, vol. 21, No. 8, pp. 1118-1123. |
Medcomp, For Access via the Internal Jugular Vein . . . The Medcomp TESIO Catheter is the Solution: The Short and Long Term Solution to Subclavian Venin Stenosis and Difficult Access Problems, Brochure, 4 pages, 1991. |
Medcomp® Brochure , “Ash Split Cath™ XL”, Dec. 2001, PN 2291. |
Medcomp® Brochure , “Ash Split Cath™”, Guidewire Weave Insertion Technique, Jan. 2002, PN 2296. |
Medcomp® Brochure , “Ash Split Cath™”, Jul. 2001, PN 2114. |
Medcomp® Brochure , “Ash Split Cath™”, Nov. 1997, PN 2050. |
Medcomp® Brochure , “Ash Split Cath® II ”, Aug. 2002, PN 2334. |
Medcomp® Brochure , “Magna™ High Flow Catheter”, Mar. 2002, PN 2321. |
Moss et al, Use of Silicone Dual-Lumen Catheter with a Dacron Cuff as a Long Term Vascular Access for Hemodialysis Patients, Amer J Kidney Diseases, vol. XVI, No. 3, pp. 211-215, Sep. 1990. |
Moss, et al., Use of a Silicone Catheter With a Dacron Cuff for Dialysis Short-Term Vascular Access, American Journal of Kidney Diseases, 1988, vol. XII, No. 6, pp. 492-498. |
Myers, R.D. et al, New Double-lumen Polyethylene Cannula for Push-pull Perfusion of Brain Tissue in Vivo, Journal of Neuroscience Methods, pp. 205-218, vol. 12, 1985. |
Northsea, C., Using Urokinase to Restore Patency in Double Lumen Catheters, ANNA Journal 1994, vol. 21, No. 5, pp. 261-273. |
OriGen, OriGen Biomedical Dual Lumen Catheter, from <http://origen.neticatheter.html>, downloaded May 13, 2009, 4 pages (reprinted for submission on Jul. 21, 2011). |
Parsa, et al., Establishment of Intravenous Lines for Long-term Intravenous Therapy and Monitoring, Surgical Clinics of N. Am. 1985, vol. 65, No. 4, pp. 835-865. |
Parsa, et al., Vascular Access Techniques, Textbook of Critical Care, W.B. Saunders, Philadelphia, PA (1989), pp. 122-127. |
Pasquale, et al., Groshong® Versus Hickman® Catheters, Surgery, Gynecology & Obstetrics, 1992, vol. 174, pp. 408-410. |
Passaro, et al., Long-term Silastic Catheters and Chest Pain, Journal of Parenteral and Enteral Nutrition, 1994, vol. 18, No. 3, pp. 240-242. |
Patel et al., “Sheathless Technique of Ash Split-Cath Insertion”, 12 JVIR 376-78 (Mar. 2001). |
Paulsen, et al., Use of Tissue Plasminogen Activator for Reopening of Clotted Dialysis Catheters, Nephron, 1993, vol. 64, pp. 468-470. |
PCT/US2003/003751 filed Feb. 7, 2003 Preliminary Examination Report dated May 5, 2004. |
PCT/US2003/003751 filed Feb. 7, 2003 Search Report dated Jul. 3, 2003. |
PCT/US2004/005102 filed Feb. 19, 2004 Preliminary Report Patenability dated Aug. 29, 2005. |
PCT/US2004/005102 filed Feb. 19, 2004 Search Report dated Dec. 27, 2004. |
PCT/US2004/005102 filed Feb. 19, 2004 Written Opinion dated Aug. 21, 2005. |
PCT/US2008/078551 filed Oct. 2, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010. |
PCT/US2008/078551 filed Oct. 2, 2008 Search Report dated Mar. 13, 2009. |
PCT/US2008/078551 filed Oct. 2, 2008 Written Opinion dated Mar. 13, 2009. |
PCT/US2008/078560 filed Oct. 2, 2008 Preliminary Report on Patentability dated Aug. 26, 2010. |
Arrow Cannon II Plus Brochure, 2006. |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Dr. Karim Valji (Jul. 17, 2008). |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Kenneth Todd Cassidy (Jul. 16, 2008). |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Rebecca R. Eisenberg in Opposition to Defendant's Motion for Partial Summary Judgment of Invalidity (Jun. 8, 2009). |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Memorandum of Law in Support of Defendant's Motion for Summary Judgment on Invalidity [Redacted Pursuant to Jun. 10, 2008 Order on Motion to Seal]. |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Memorandum of Law in Support of Defendant's Motion for Summary Judgment on Invalidity Exhibit a (Jul. 10, 2009). |
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Plaintiffs Memorandum in Opposition to Defendant's Motion for Summary Judgement on Non-Infringement (Jul. 17, 2008). |
Arrow International, Inc. et al. v. Spire Biomedical, Inc., U.S. Dist. Ct. Dist. MA CA No. 06-CV-11564-DPW, Defendant's Omnibus Statement of Material Facts in Support of its Motions for Summary Judgment (Jun. 10, 2008) [Redacted Pursuant to Jun. 10, 2008 Order on Motion to Seal]. |
Bander, et al., Central Venous Angioaccess for Hemodialysis and Its Complications, Seminars in Dialysis, 1992, vol. 5, No. 2, pp. 121-128. |
Baranowski, L., Central Venous Access Devices, Journal of Intravenous Nursing, 1993, vol. 16, No. 3, pp. 167-194. |
Bard Access Systems Hickman@ , Leonard@ , and Broviac® Central Venous Catheters (Long Term), Instructions for Use, 31 pages, 1999. |
Bard Access Systems Hickman@ , Leonard@ , and Broviac® Central Venous Catheters, Nursing Procedural Manual, 52 pages, Jun. 1994. |
Bard Davol® Hickman® Round Dual Lumen Catheters for Central Venous Access Informational Brochure, 4 pages, 1994. |
Bard Hickman® Catheters Informational Brochure, 3 pages, 1994. |
Believed to be an unpublished sketch of a conception by Dr. John Frusha; date of sketch believed to be Jun. 24, 1997. |
Berkoben, et al., Maintenance of Permanent Hemodialysis Vascular Access Patency, ANNA Journal, 1995, vol. 22, No. 1, pp. 17-24. |
Bolz, et al., Catheter Malfunction and Thrombus Formation on Double-Lumen Hemodialysis Catheters: An Intravascular Ultrasonographic Study, American Journal of Kidney Diseases, 1995, vol. 25, No. 4, pp. 597-602. |
Bour, et al., Experience With the Double Lumen Silastic® Catheter for Hemoaccess, Surgery, Gynecology & Obstetrics, 1990, vol. 171, pp. 33-39. |
Camp, “Care of the Groshong Catheter”, Oncol Nurs Forum, vol. 15, No. 6, 1988. |
Campbell, et al., Radiological Insertion of Long-term Venous Access Devices, Seminars in Interventional Radiology, 1994, vol. II, No. 4, pp. 366-375. |
Canaud, B et al, Permenant Twin Catheter: A Vascular Access Option of Choice for Haemodialysis in Elderly Patients, pp. 82-88, vol. 17 No. 7, 1994. |
Claim Construction Order of Federal District Court dated May 9, 2003 in Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc. litigation (S.D. N.Y. 03 Civ.0972). |
Claim Construction Order of Federal District Court dated Oct. 31, 2006 in Arrow Int'l Inc.and Arrow Int'l. Investment Corp. v. Spire Biomedical, Inc. litigation (D. Mass. Civil Action No. 06-CV-11564). |
CN 200880121182.0 filed Oct. 20, 2008 First Office Action dated May 2, 2012. |
CN 200880121183.5 filed Oct. 2, 2008 First Office Action dated Mar. 28, 2012. |
CN 200880121183.5 filed Oct. 2, 2008 Second Office Action dated Aug. 17, 2012. |
CN 200880121183.5 filed Oct. 2, 2008 Third Office Action dated Dec. 11, 2012. |
CN 200880123095.9 filed Oct. 20, 2008 First Office Action dated Feb. 13, 2012. |
CN 200880123095.9 filed Oct. 20, 2008 Second Office Action dated Dec. 18, 2012. |
CN 200880123533.1 filed Jun. 30, 2008 First Office Action dated May 28, 2012. |
CN 200880123533.1 filed Jun. 30, 2008 Notice of Grant dated Dec. 24, 2012. |
Declaration of Gregory S. Haas (Plaintiff's Exhibit 88 in Haas Deposition), Mar. 13, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.). |
Defendant's Exhibits DX78-DX114, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.), 2003. |
Defendants' Reponses and Objections to Plaintiffs' Second Set of Interrogatories (Excerpt), Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.) (Oct. 8, 2003). |
Delmore et al., “Experience with the Groshong Long-Term Central Venous Catheter”, Gynecologic Oncology 34, 216-218 (1989). |
Dialysis Vascular Access, SchonXL® Temporary Dialysis (AngioDynamics Inc.) brochure, Nov. 1998. |
Dialysis Vascular Access, Technological Innovations Improving Flow (AngioDynamics Inc.) Brochure, 4 pages, Nov. 1998. |
Difiore, “Central Venous Dialysis Catheter Evaluatio in Swine”, Journal of Vascular Access Devices, Fall 2000. |
Donaldson, et al., Peripherally Inserted Central Venous Catheters: US-guided Vascular Access in Pediatric Patientsl, Radiology, 1995, vol. 197, pp. 542-544. |
Dunea, et. al., A Survey of Permanent Double Lumen Catheters in Hemodialysis Patients. Asaio Transac. 1991; 37: M276-7. |
Dupont et al, Long-term development of Permacath Quinton catheters used as a vascular access route for extra-renal detoxification; Néphrologie, vol. 15, pp. 105-110, 1994. |
EP 04712925.9 filed Feb. 19, 2004 Office Action dated Nov. 7, 2008. |
EP 08839196.6 filed Oct. 2, 2008 Examination Report dated Jan. 16, 2013. |
EP 08839196.6 filed Oct. 2, 2008 Search Opinion dated Jul. 12, 2011. |
EP 08839196.6 filed Oct. 2, 2008 Search Report dated Jul. 12, 2011. |
EP 08872340.8 filed Oct. 2, 2008 Extended European Search Report and an Opinion dated Apr. 19, 2012. |
Gallichio, et al., Placement of a Double Lumen Silastic Catheter for Hemodialysis Access Through the Cephalic Vein, Journal of the American College of Surgeons, 1994, vol. 179, pp. 171-172. |
Gravenstein, et al., In Vitro Evaluation of Relative Perforating Potential of Central Venous Catheters: Comparison of Materials, Selected Models, Number of Lumens, and Angles of Incidence to Simulated Membrane, Journal of Clinical Monitoring, 1991, vol. 7, pp. 1-6. |
Haindl, H., Technical complications of port-catheter systems, Reg. Cancer Treat, 1989, 2:238-242. |
U.S. Appl. No. 10/842,586 filed May 10, 2004 Non-Final Office Action dated Jan. 7, 2008. |
U.S. Appl. No. 10/842,586 filed May 10, 2004 Non-Final Office Action dated Jun. 16, 2009. |
U.S. Appl. No. 10/842,586 filed May 10, 2004 Non-Final Office Action dated Nov. 13, 2008. |
U.S. Appl. No. 10/842,586 filed May 10, 2004 Non-Final Office Action dated Nov. 23, 2009. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Advisory Action dated Feb. 19, 2009. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Final Office Action dated Jul. 15, 2008. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Final Office Action dated Jul. 7, 2010. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Final Office Action dated Mar. 18, 2014. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Aug. 1, 2013. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Aug. 18, 2011. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Dec. 30, 2009. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Feb. 2, 2011. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Jul. 23, 2009. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated May 23, 2006. |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated May 24, 2007. |
U.S. Appl. No. 11/859,106 filed Sep. 21, 2007 Final Office Action dated Sep. 1, 2009. |
U.S. Appl. No. 11/859,106 filed Sep. 21, 2007 Non-Final Office Action dated Feb. 5, 2009. |
U.S. Appl. No. 11/859,106 filed Sep. 21, 2007 Non-Final Office Action dated Mar. 30, 2011. |
U.S. Appl. No. 11/859,106 filed Sep. 21, 2007 Non-Final Office Action dated Jun. 25, 2008. |
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Decision on Appeal dated Dec. 26, 2012. |
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Examiners Answer dated Apr. 28, 2010. |
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Final Office Action dated Jul. 22, 2009. |
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Non-Final Office Action dated Jan. 6, 2009. |
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Non-Final Office Action dated Jul. 12, 2013. |
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Non-Final Office Action dated Jul. 9, 2008. |
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Notice of Allowance dated Apr. 18, 2014. |
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Examiner's Answer dated Feb. 9, 2012. |
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Final Office Action dated Jan. 20, 2011. |
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Non-Final Office Action dated Jan. 7, 2010. |
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Non-Final Office Action dated Jul. 7, 2010. |
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Non-Final Office Action dated May 12, 2009. |
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Final Office Action dated Jun. 19, 2012. |
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Non-Final Office Action dated Jan. 17, 2012. |
U.S. Appl. No. 12/244,559 filed Oct. 2, 2008 Examiners Answer dated Mar. 27, 2013. |
U.S. Appl. No. 12/244,559 filed Oct. 2, 2009 Final Office Action dated Jul. 3, 2012. |
U.S. Appl. No. 12/244,559 filed Oct. 2, 2009 Non-Final Office Action dated Mar. 14, 2012. |
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Advisory Action dated Sep. 5, 2012. |
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Final Office Action dated Jul. 11, 2011. |
U.S. Appl. No. 12/244,514 filed Oct. 2, 2008 Non-Final Office Action dated Jan. 19, 2011. |
U.S. Appl. No. 12/244,544 filed Oct. 2, 2008 Final Office Action dated Jul. 11, 2011. |
U.S. Appl. No. 12/244,544 filed Oct. 2, 2008 Non-Final Office Action dated Dec. 22, 2010. |
U.S. Appl. No. 12/244,554 filed Oct. 2, 2008 Final Office Action dated Dec. 27, 2010. |
U.S. Appl. No. 12/244,554 filed Oct. 2, 2008 Non-Final Office Action dated Jul. 6, 2010. |
U.S. Appl. No. 12/253,870 filed Oct. 17, 2008 Non-Final Office Action dated Jan. 21, 2011. |
U.S. Appl. No. 12/253,870 filed Oct. 17, 2008 Notice of Allowance dated Aug. 19, 2011. |
U.S. Appl. No. 12/262,820 filed Oct. 31, 2008 Non-Final Office Action dated Feb. 18, 2011. |
U.S. Appl. No. 12/262,820 filed Oct. 31, 2008 Notice of Allowance dated Sep. 28, 2011. |
U.S. Appl. No. 12/263,141 filed Oct. 31, 2008 Advisory Action dated Aug. 17, 2011. |
U.S. Appl. No. 12/263,141 filed Oct. 31, 2008 Final Office Action dated May 26, 2011. |
U.S. Appl. No. 12/263,141 filed Oct. 31, 2008 Non-Final Office Action dated Jan. 5, 2011. |
U.S. Appl. No. 12/414,467 filed Mar. 30, 2009 Final Office Action dated Feb. 7, 2012. |
U.S. Appl. No. 12/414,467 filed Mar. 30, 2009 Notice of Allowance dated May 31, 2012. |
U.S. Appl. No. 12/414,467 filed Mar. 30, 2009 Non-Final Office Action dated Aug. 11, 2011. |
U.S. Appl. No. 13/294,941 filed Nov. 11, 2011 Non-Final Office Action dated May 31, 2013. |
U.S. Appl. No. 13/294,941 filed Nov. 11, 2011 Notice of Allowance dated Nov. 27, 2013. |
U.S. Appl. No. 13/445,713 filed Apr. 12, 2012 Advisory Action dated Aug. 8, 2013. |
U.S. Appl. No. 13/445,713 filed Apr. 12, 2012 Final Office Action dated May 30, 2013. |
U.S. Appl. No. 13/445,713 filed Apr. 12, 2012 Non-Final Office Action dated Jan. 2, 2013. |
U.S. Appl. No. 13/445,713 filed Apr. 12, 2012 Notice of Allowance dated Oct. 18, 2013. |
US Patent File History U.S. Pat. No. 5,403,291 (Abrahamson), issued Apr. 4, 1995. |
US Patent File History U.S. Pat. No. 5,489,278 (Abrahamson), issued Feb. 6, 1996. |
US Patent File History U.S. Pat. No. 5,685,867 (Twardowski et al.), issued Nov. 11, 1997. |
Wechsler, et al., Thrombosis and Infection Caused by Thoracic Venous Catheters: Pathogenesis and Imagings Findings, AJR, 1993; 160:467-471. |
Weitzel, et al, Successful Use of Indwelling Cuffed Femoral Vein Catheters in Ambulatory Hemodialysis Patients, American Journal of Kidney Diseases, 1993, vol. 22, No. 3, pp. 426-429. |
PCT/US2008/078560 filed Oct. 2, 2008 Search Report dated Mar. 16, 2009. |
PCT/US2008/078560 filed Oct. 2, 2008 Written Opinion dated Mar. 16, 2009. |
PCT/US2008/078566 filed Oct. 2, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010. |
PCT/US2008/078566 filed Oct. 2, 2008 Search Report dated Mar. 19, 2009. |
PCT/US2008/078566 filed Oct. 2, 2008 Written Opinion dated Mar. 19, 2009. |
PCT/US2008/078571 filed Oct. 2, 2008 Preliminary Report on Patentability dated Aug. 26, 2010. |
PCT/US2008/078571 filed Oct. 2, 2008 Search Report dated Mar. 20, 2009. |
PCT/US2008/078571 filed Oct. 2, 2008 Written Opinion dated Mar. 20, 2009. |
PCT/US2008/080463 filed Oct. 20, 2008 Preliminary Report on Patentability dated Apr. 27, 2010. |
PCT/US2008/080463 filed Oct. 20, 2008 Search Report dated Mar. 16, 2009. |
PCT/US2008/080463 filed Oct. 20, 2008 Written Opinion dated Apr. 16, 2009. |
PCT/US2008/082106 filed Oct. 31, 2008 International Preliminary Report on Patentability dated May 4, 2010. |
PCT/US2008/082106 filed Oct. 31, 2008 Search Report dated Jan. 12, 2009. |
PCT/US2008/082106 filed Oct. 31, 2008 Written Opinion dated Jan. 12, 2009. |
Picture of Device believed to be partial sample of a product believed to have been sold in the United States with Polycath and/or Infuse-a-Cath Instructions for Use, 1 page, 2011. |
Quinton® Catheter Products (1993). |
Raaf Dual Lumen Right Atrial Catheters Brochure—Quinton Instrument Co., 6 pages, 1993. |
Raaf, et al., Open Insertion of Right Atrial Catheters Through the Jugular Veins, Surgery, Gynecology & Obstetrics, 1993, vol. 177, pp. 295-298. |
Rawn, et al., The Hemodialysis Access, Chapter 9, pp. 9.1-9.11, available at <<http://msl1.mit.edu/ESD10/kidneys/HndbkPDF/Chap09.pdf>>, last accessed Jun. 4, 2012. |
Schwab, et al., Prospective Evaluation of a Dacron Cuffed Hemodialysis Catheter for Prolonged Use, American Journal of Kidney Diseases, 1988, vol. XI, No. 2, pp. 166-169. |
Schwab, et al., Vascular Access: Case Oriented Discussions of Selected Critical Issues: Hemodialysis Catheters for Permanent Use, 1999. |
Shaffer, D., Catheter-Related Sepsis Complicating Long-Term Tunnelled Central Venous Dialysis Catheters: Management by Guidewire Exchange, American Journal of Kidney Diseases, 1995, vol. 25, No. 4, pp. 593-596. |
Shaffer, D., Lessons From Vascular Access Procedures for Hemodialysis, Surgical Oncology Clinics of North America, 1995, vol. 4, No. 3, pp. 537-549. |
Sioshansi, P., New Processes for Surface Treatment of Catheters, Artificial Organs, 1994, 18(4):266-271. |
Swartz, et al., Successful Use of Cuffed Centrol Venous Hemodialysis Catheters Inserted Percutaneously, J. Am. Soc. Nephrol., 1994, 4:1719-1725. |
Tal, Michael G, Comparison of Recirculation Percentage of the Palindrome Catheter and Standard Hemodialysis Catheters in a Swine Model, J Vasc Intery Radiol, pp. 1237-1240, vol. 16, No. 9, 2005. |
Tesio, et al., Double Catheterization of the Internal Jugular Vein for Hemodialysis: Indications, Techniques, and Clinical Results, Artificial Organs, 1994, vol. 18, No. 4, pp. 301-304. |
The Groshong™ Peripherally Inserted Central Venous Catheter Brochure—Cath-tech®, 4 pages, 1988. |
Transcript of Videotaped Deposition of Gregory Haas (Excerpt), Sep. 23, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-Cv-0972 (S.D.N.Y.). |
Transcript of Videotaped Deposition of Thierry Pourchez, vol. 1, Oct. 16, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.). |
Transcript of Videotaped Deposition of Thierry Pourchez, vol. 2, Oct. 17, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.). |
Treiman, et al., Chronic Venous Access in Patients with Cancer, Cancer, 1993, vol. 72, No. 3, pp. 760-765. |
Twardowski et al. “Side Holes at the Tip of Chronic Hemodialysis Catehters are Harmful,” The Journal of Vascular Access 2001; 2:8-16. |
Twardowski et al., “Blood Recirculation in Intravenous Catheters for Hemodialysis” J. Am. Soc. Nephrol. 3:1978-81 (1993). |
Tyco Healthcare, Mahurkar Dual Lumen Catheters, Informational Brochure, 2 pages, 2004. |
Tyco Healthcare, Mahurkar QPlus High Flow Acute Care Catheter, Informational Brochure, 2 pages, 2004. |
Tyco Healthcare, Tal Palindrome™ Dual Lumen Catheters Order Information, Features and Benefits, Frequently Asked Questions, printed from http://www.kendallvasculartherapy.com/VascularTherapy, 6 pages, on Mar. 1, 2007. |
Uldall, P., Subclavian Cannulation Is No Longer Necessary or Justified in Patients with End-Stage Renal Failure, Seminars in Dialysis, 1994, vol. 7, No. 3, pp. 161-164. |
U.S. Appl. No. 10/371,774 filed Feb. 21, 2003 Final Office Action dated Jan. 19, 2007. |
U.S. Appl. No. 10/371,774 filed Feb. 21, 2003 Final Office Action dated Mar. 7, 2007. |
U.S. Appl. No. 10/371,774 filed Feb. 21, 2003 Non-Final Office Action dated Jul. 17, 2006. |
U.S. Appl. No. 10/371,774 filed Feb. 21, 2003 Notice of Allowance dated Jun. 1, 2007. |
U.S. Appl. No. 10/445,731 filed May 27, 2003 Non-Final Office Action dated Apr. 13, 2007. |
U.S. Appl. No. 10/445,731 filed May 27, 2003 Non-Final Office Action dated Dec. 12, 2008. |
U.S. Appl. No. 10/445,731 filed May 27, 2003 Non-Final Office Action dated May 30, 2008. |
U.S. Appl. No. 10/842,586 filed May 10, 2004 Advisory Action dated Oct. 9, 2008. |
U.S. Appl. No. 10/842,586 filed May 10, 2004 Final Office Action dated Jul. 29, 2008. |
U.S. Appl. No. 10/842,586 filed May 10, 2004 Final Office Action dated May 25, 2010. |
CN 201310073124.8 filed Mar. 7, 2013 First Office Action dated May 5, 2014. |
JP 2010-532299 filed Apr. 30, 2010 Final Notice of Reason for Rejection dated Feb. 8, 2013. |
PCT/US2014/066811 filed Nov. 21, 2014 International Search Report and Written Opinion dated Apr. 15, 2015. |
Septum, Wikipedia, The Free Encyclopedia, hhtp://en.wikipedia.org/wiki/Septum (last visited Dec. 18, 2012) (defining “septum” as “a wall, dividing a cavity or structure into smaller ones”). |
Taber's Cyclopedic Medical Dictionary 1662 (16th ed. 1989) (defining “septum” as a “wall dividing two cavities”). |
U.S. Appl. No. 10/874,298 filed Jun. 9, 2004 Non-Final Office Action dated Jul. 9, 2014. |
U.S. Appl. No. 12/048,871 filed Mar. 14, 2008 Decision on Appeal dated Feb. 2, 2015. |
U.S. Appl. No. 13/329,156 filed Dec. 16, 2011 Non-Final Office Action dated May 16, 2014. |
U.S. Appl. No. 13/897,292 filed May 17, 2013 Final Office Action dated Apr. 9, 2015. |
U.S. Appl. No. 13/897,292 filed May 17, 2013 Non-Final Office Action dated Nov. 20, 2014. |
U.S. Appl. No. 14/032,858 filed Sep. 20, 2013 Final Office Action dated Mar. 31, 2015. |
U.S. Appl. No. 14/032,858 filed Sep. 20, 2013 Non-Final Office Action dated Nov. 4, 2014. |
U.S. Appl. No. 14/252,567 filed Apr. 14, 2014 Non-Final Office Action dated Mar. 31, 2015. |
U.S. Appl. No. 14/094,534, filed Dec. 2, 2013 Non-Final Office Action dated Feb. 24, 2016. |
Number | Date | Country | |
---|---|---|---|
20140330220 A1 | Nov 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11874447 | Oct 2007 | US |
Child | 14328541 | US | |
Parent | 10371774 | Feb 2003 | US |
Child | 11874447 | US |